Content about Chickenpox

January 22, 2014

A new study from researchers at Ohio State University is reporting that older patients who receive written information on shingles were almost three times more likely to get vaccinated than those that didn’t receive a similar communication.

COLUMBUS, Ohio - A new study from researchers at Ohio State University is reporting that older patients who receive written information on shingles were almost three times more likely to get vaccinated than those that didn’t receive a similar communication. The study is also one of the first to show that using a patient’s electronic medical record coupled with pharmacist intervention markedly improves preventative care of shingles over the current standard.

December 4, 2013

The program to vaccinate children against chickenpox introduced in 1996 does not seem to be behind an increase in recent years in the number of cases of shingles, according to a new study.

NEW YORK — The program to vaccinate children against chickenpox introduced in 1996 does not seem to be behind an increase in recent years in the number of cases of shingles, according to a new study.

October 9, 2013

Flu is at the top of the list of diseases older adults plan to ask about, according to results from a new Harris Interactive consumer awareness survey, sponsored by Merck. Most of the more than 600 surveyed adults age 60 years and older are at least somewhat likely to ask their healthcare professional about preventing the flu this year, and are significantly more likely to ask about this than prevention of such other potentially serious diseases as shingles.

WHITEHOUSE STATION, N.J. — Flu is at the top of the list of diseases older adults plan to ask about, according to results from a new Harris Interactive consumer awareness survey, sponsored by Merck. Most of the more than 600 surveyed adults age 60 years and older are at least somewhat likely to ask their healthcare professional about preventing the flu this year, and are significantly more likely to ask about this than prevention of such other potentially serious diseases as shingles.

September 16, 2013

Actavis has launched a generic drug for post-shingles pain under an agreement with the branded drug's manufacturers, the company said Monday.

PARSIPPANY, N.J. — Actavis has launched a generic drug for post-shingles pain under an agreement with the branded drug's manufacturers, the company said Monday.

Actavis announced the launch of generic lidocaine topical patches in the 5% strength under a settlement agreement with Endo Pharmaceuticals and Teikoku Seiyaku Co. The drug is a generic version of Lidoderm, and Actavis said it was likely the first company to win approval for the generic from the Food and Drug Administration, thus entitling it to 180 days in which to compete exclusively against the branded version.

December 21, 2012

The Food and Drug Administration has approved a new drug for reducing the severity of chickenpox symptoms, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for reducing the severity of chickenpox symptoms, the agency said Friday.

The FDA announced the approval of Cangene Corp.'s Varizig (varicella zoster immune globulin [human]) for varicella zoster, the virus that causes chickenpox. The FDA said Varizig was the only FDA-approved immune globulin for the virus after exposure.

September 26, 2012

A drug maker is suing the Food and Drug Administration to force the agency to give a special designation to one of its drugs.

MENLO PARK, Calif. — A drug maker is suing the Food and Drug Administration to force the agency to give a special designation to one of its drugs.

Depomed announced that it had filed suit against the FDA in federal district court for the District of Columbia seeking an order that would require the agency to grant the drug Gralise (gabapentin) orphan drug exclusivity for the management of post-herpetic neuralgia. The disease, also known as PHN, is a condition causing prolonged pain in people who have had shingles, a complication of chickenpox.

July 26, 2011

Chickenpox is the scourge of many a schoolchild and usually a convenient, if itchy and feverish, reason to stay home for several days, but it also has been fatal for many who catch it — until recently.

ELK GROVE VILLAGE, Ill. — Chickenpox is the scourge of many a schoolchild and usually a convenient, if itchy and feverish, reason to stay home for several days, but it also has been fatal for many who catch it — until recently.

According to a new study published in the journal Pediatrics, since a vaccine for varicella, the virus that causes chickenpox, became available in 1995, deaths from the virus have been virtually eliminated.

April 25, 2011

The pharmacist isn’t just someone in a white coat who hands out bottles of pills anymore. The role of pharmacists has been changing and expanding dramatically over the last several years.

Now, pharmacists in all 50 states can offer a service previously reserved for doctors and nurses: 
administering vaccinations. Retail pharmacies across the country are racing to join the immunization trend, with Weis Markets recently announcing that it would spend the year making sure all its pharmacists were trained to give vaccinations. 


March 29, 2011

A decision by the Food and Drug Administration to lower the age at which patients can receive a vaccine for shingles opens the door for pharmacists to administer it to more patients.

CAMP HILL, Pa. — A decision by the Food and Drug Administration to lower the age at which patients can receive a vaccine for shingles opens the door for pharmacists to administer it to more patients.

Rite Aid said Tuesday that pharmacists at more than 2,100 of its stores now could vaccinate patients ages 50 years and older with Merck’s Zostavax (zoster vaccine live) thanks to the FDA’s approval of the vaccination for patients in that age group. Previously, it was only approved for patients ages 60 years and older.

March 25, 2011

The Food and Drug Administration has approved a vaccine for shingles in older patients.

SILVER SPRING, Md. — The Food and Drug Administration has approved a vaccine for shingles in older patients.

The agency said Thursday that it had approved Merck’s Zostavax (zoster vaccine live) vaccine in patients ages 50 to 59 years. The vaccine already is approved for those ages 60 years and older.

Shingles, caused by the varicella-zoster virus, the same virus that causes chickenpox, affects about 200,000 people in the United States ages 50 to 59 years each year.

February 14, 2011

With shingles vaccines widely reported to be in short supply from some healthcare providers, Walgreens on Monday announced the expansion of its availability of Zostavax — a one-time vaccine that can reduce the risk of shingles in individuals ages 60 years and older — and now is offering shingles vaccinations daily at more than 2,000 Walgreens stores and Take Care Clinics.

DEERFIELD, Ill. — With shingles vaccines widely reported to be in short supply from some healthcare providers, Walgreens on Monday announced the expansion of its availability of Zostavax — a one-time vaccine that can reduce the risk of shingles in individuals ages 60 years and older — and now is offering shingles vaccinations daily at more than 2,000 Walgreens stores and Take Care Clinics.

January 12, 2010

Rite Aid on Wednesday announced the launch of a national shingles vaccination and education campaign...